Interferon-inducible transmembrane proteins (IFITMs) exhibit broad antiviral activity, both in cell culture and in vivo. IFITM expression has been shown to prevent infection of important human pathogens, including influenza, Ebola, West Nile and SARS viruses, by blocking viral fusion with target cells. The existence of IFITM-resistant viruses, such as Murine Leukemia and Lassa viruses, suggests that restriction occurs in a cellular compartment- specific manner. The mechanism by which fusion of diverse viruses is inhibited by IFITMs and the escape mechanisms from IFITM restriction are not understood, due in part to difficulties associated with visualization of their dynamic distribution in living cells. We made and validated functional fluorescently-tagged IFITM proteins and imaged, for the first time, single virus/IFITM co-trafficking and fusion. Pilot experiments suggest that viruses that co-traffic with IFITMs are trapped at a hemifusion stage, unable to form a fusion pore, whereas resistant viruses appear to be transported through endosomes devoid of IFITMs. We also discovered a novel role for phosphoinositides in viral fusion and the IFITM restriction phenotype. Our working hypothesis is that IFITMs block virus entry by: (i) trapping viral fusion at a dead-end hemifusion stage through by altering the properties of cell membranes; and (ii) favoring non-productive fusion with intralumenal vesicles within enlarged multivesicular compartments. We will test the working hypothesis using a panel of validated IFITM-sensitive and ?resistant pseudoviruses and a powerful combination of virology, cell biology, membranebiophysics and advanced imaging techniques. Specifically, we will: (1) elucidate whether dynamic colocalization of IFITMs with viruses is a prerequisite for restriction; (2) determine whether IFITMs inhibit viral fusion by altering the mechanical properties of cell membranes that disfavor the transition from hemifusion to full fusion and/or through diverting the virus entry to a non-productive pathway; and (3) delineate the role of phosphoinositides in the IFITM restriction phenotype. Insights into the mechanism of IFITM-mediated virus restriction will provide important clues on how cells mount efficient antiviral responses and suggest new strategies for preventing infection.
Interferon-inducible transmembrane proteins (IFITMs) block infection of a number of unrelated viruses, such as influenza and Ebola, in cell culture and in animal models. However, the mechanism by which IFITMs exert such broad antiviral activity is currently not understood. We propose to investigate the mechanism of IFITM- mediated virus restriction by employing a powerful combination of cell biology and advanced imaging techniques.
